84 related articles for article (PubMed ID: 25407510)
1. Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides.
Poorinmohammad N; Mohabatkar H; Behbahani M; Biria D
J Pept Sci; 2015 Jan; 21(1):10-6. PubMed ID: 25407510
[TBL] [Abstract][Full Text] [Related]
2. Predicting anticancer peptides with Chou's pseudo amino acid composition and investigating their mutagenicity via Ames test.
Hajisharifi Z; Piryaiee M; Mohammad Beigi M; Behbahani M; Mohabatkar H
J Theor Biol; 2014 Jan; 341():34-40. PubMed ID: 24035842
[TBL] [Abstract][Full Text] [Related]
3. Computational prediction of antifungal peptides via Chou's PseAAC and SVM.
Mousavizadegan M; Mohabatkar H
J Bioinform Comput Biol; 2018 Aug; 16(4):1850016. PubMed ID: 30105927
[TBL] [Abstract][Full Text] [Related]
4. Chimeric synthetic peptides from the nucleocapsid p24 protein of human immunodeficiency virus type-1.
Hernández M; Rodríguez I; Pozo L; Rivero J
Biochem Biophys Res Commun; 2001 Mar; 282(1):1-3. PubMed ID: 11263961
[TBL] [Abstract][Full Text] [Related]
5. Insertion of a short human immunodeficiency virus (HIV)-2 gp36 sequence into an HIV-1 p24 recombinant protein results in a polypeptide with potent and TCRBV-restricted T cell triggering activity.
Imberti L; Sottini A; Quiròs Roldan E; Albertini A; Mattioli S; Prati E; Primi D
Eur J Immunol; 1995 Jan; 25(1):218-25. PubMed ID: 7843234
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
7. Predicting antibacterial peptides by the concept of Chou's pseudo-amino acid composition and machine learning methods.
Khosravian M; Faramarzi FK; Beigi MM; Behbahani M; Mohabatkar H
Protein Pept Lett; 2013 Feb; 20(2):180-6. PubMed ID: 22894156
[TBL] [Abstract][Full Text] [Related]
8. Prediction of HIV-1 and HIV-2 proteins by using Chou's pseudo amino acid compositions and different classifiers.
Mei J; Zhao J
Sci Rep; 2018 Feb; 8(1):2359. PubMed ID: 29402983
[TBL] [Abstract][Full Text] [Related]
9. A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1.
Galatola R; Vasconcelos A; Pérez Y; Cruz A; Pujol M; Alsina MA; Gómara MJ; Haro I
Eur J Med Chem; 2014 Oct; 86():589-604. PubMed ID: 25218908
[TBL] [Abstract][Full Text] [Related]
10. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
11. [Comparative evaluation of Hebei HIV-1 p24 kit for the detection of human immunodeficiency virus].
Yang YS; Wang RT; Zhang XG; Zhang HZ; Wang HF; Li ZL; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):8-10. PubMed ID: 17429521
[TBL] [Abstract][Full Text] [Related]
12. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight anti-HIV-1 peptides from the amino-terminal sequence of RANTES: possible lead compounds for coreceptor-directed anti-HIV-1 agents.
Nishiyama Y; Murakami T; Kurita K; Yamamoto N
Bioorg Med Chem Lett; 1999 May; 9(10):1357-60. PubMed ID: 10360735
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 capsid assembly inhibitor (CAI) peptide: structural preferences and delivery into human embryonic lung cells and lymphocytes.
Braun K; Frank M; Pipkorn R; Reed J; Spring H; Debus J; Didinger B; von der Lieth CW; Wiessler M; Waldeck W
Int J Med Sci; 2008 Jul; 5(5):230-9. PubMed ID: 18695744
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
Hochleitner EO; Borchers C; Parker C; Bienstock RJ; Tomer KB
Protein Sci; 2000 Mar; 9(3):487-96. PubMed ID: 10752610
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to six synthetic peptides of capsid protein with sera from HIV-1 infected individuals.
Liu G; Yang L; Wang J; Zhang G; Chen X; Zheng Y
Cell Mol Immunol; 2005 Aug; 2(4):289-93. PubMed ID: 16274627
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of LC5, the CCR5- derived peptide for HIV-1 inhibition.
Miyamoto K; Togiya K; Kitahara R; Akasaka K; Kuroda Y
J Pept Sci; 2010 Apr; 16(4):165-70. PubMed ID: 20196122
[TBL] [Abstract][Full Text] [Related]
18. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
[TBL] [Abstract][Full Text] [Related]
19. Cooperative effects in phospholipid monolayers induced by a peptide from HIV-1 capsid protein.
Moraes ML; Bonardi C; Mendonça CR; Campana PT; Lottersberger J; Tonarelli G; Oliveira ON; Beltramini LM
Colloids Surf B Biointerfaces; 2005 Mar; 41(1):15-20. PubMed ID: 15698751
[TBL] [Abstract][Full Text] [Related]
20. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran.
Ghoneum M
Biochem Biophys Res Commun; 1998 Feb; 243(1):25-9. PubMed ID: 9473473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
